On Monday, Mimedx Group Inc (NASDAQ: MDXG) was 4.63% up from the session before settling in for the closing price of $6.26. A 52-week range for MDXG has been $5.57 – $9.27.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales drop of Healthcare Sector giant was -1.19%. When this article was written, the company’s average yearly earnings per share was at -27.03%. With a float of $114.69 million, this company’s outstanding shares have now reached $146.23 million.
Let’s determine the extent of company efficiency that accounts for 895 employees. In terms of profitability, gross margin is 83.3%, operating margin of 21.86%, and the pretax margin is 20.29%.
Mimedx Group Inc (MDXG) Insider Activity
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Mimedx Group Inc stocks. The insider ownership of Mimedx Group Inc is 21.88%, while institutional ownership is 45.73%. The most recent insider transaction that took place on Mar 13 ’24, was worth 162,029. In this transaction General Counsel and CAO of this company sold 20,381 shares at a rate of $7.95, taking the stock ownership to the 479,959 shares. Before that another transaction happened on Feb 16 ’24, when Company’s Chief Operating Officer sold 15,493 for $8.07, making the entire transaction worth $125,075. This insider now owns 416,321 shares in total.
Mimedx Group Inc (MDXG) Earnings and Forecasts
According to the Wall Street analysts, stocks earnings will be around -27.03% per share during the next fiscal year.
Mimedx Group Inc (NASDAQ: MDXG) Trading Performance Indicators
You can see what Mimedx Group Inc (MDXG) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 3.22. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 2.82. Likewise, its price to free cash flow for the trailing twelve months is 20.27.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 0.59, a number that is poised to hit 0.05 in the next quarter and is forecasted to reach 0.32 in one year’s time.
Technical Analysis of Mimedx Group Inc (MDXG)
Looking closely at Mimedx Group Inc (NASDAQ: MDXG), its last 5-days average volume was 0.54 million, which is a drop from its year-to-date volume of 0.76 million. As of the previous 9 days, the stock’s Stochastic %D was 49.85%. Additionally, its Average True Range was 0.27.
During the past 100 days, Mimedx Group Inc’s (MDXG) raw stochastic average was set at 34.75%, which indicates a significant increase from 32.93% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 55.42% in the past 14 days, which was higher than the 48.92% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $6.89, while its 200-day Moving Average is $7.45. However, in the short run, Mimedx Group Inc’s stock first resistance to watch stands at $6.67. Second resistance stands at $6.80. The third major resistance level sits at $7.03. If the price goes on to break the first support level at $6.31, it is likely to go to the next support level at $6.08. Should the price break the second support level, the third support level stands at $5.95.
Mimedx Group Inc (NASDAQ: MDXG) Key Stats
There are 147,604K outstanding shares of the company, which has a market capitalization of 961.61 million. As of now, sales total 321,480 K while income totals 58,230 K. Its latest quarter income was 87,210 K while its last quarter net income were 17,630 K.
